Related by context. All words. (Click for frequent words.) 67 Vidaza azacitidine 66 clevidipine 66 thalidomide Thalomid 66 Interferon beta 65 alefacept 65 metastatic malignant 65 uricase 65 bleomycin 65 gemcitabine Gemzar ® 65 busulfan 65 liposomal formulation 65 urothelial bladder cancer 64 humanised monoclonal antibody 64 malignant ascites 64 cardiotoxic 64 histone deacetylase inhibitor 64 arteritis 64 selective modulator 64 intact parathyroid hormone 64 gefitinib Iressa 64 liposomal amphotericin B 64 zoledronate 64 topically administered 63 PEG IFN 63 sorafenib Nexavar 63 pretransplant 63 immune modulating 63 SYN# 63 hMG 63 COL#A# 63 recurrent glioblastoma multiforme 63 mutated K ras 63 cetuximab Erbitux ® 63 ß blockers 63 alkylating agent 63 pharmacokinetic parameters 63 MGd 63 Inosine 63 ischemia induced 63 bronchoalveolar lavage fluid 63 bortezomib Velcade 63 Elevated serum 63 recurrent metastatic 63 hA# 63 selective adenosine 63 temsirolimus Torisel ® 63 antithymocyte globulin 63 refractory chronic lymphocytic 63 peginterferon alpha 2a 63 fallopian tube cancers 63 liposomal doxorubicin 63 β blockers 63 bacillus Calmette Guerin 63 immunotoxin 63 Panzem NCD 63 nicardipine 63 Kinoid 63 murine model 62 denileukin diftitox 62 ribavirin RBV 62 tissue transglutaminase 62 prognostic biomarker 62 inhibitor RG# 62 humanized monoclonal 62 antimetabolite 62 demonstrated antitumor activity 62 etanercept Enbrel 62 chemosensitivity 62 interleukin IL -# 62 beta 1a 62 lymphoid malignancies 62 targeted nucleotide prodrug 62 bladder ovarian 62 liposome formulation 62 alpha1 antitrypsin deficiency 62 vinca alkaloid 62 replicon 62 papillary renal cell carcinoma 62 Zybrestat 62 CDK inhibitor 62 DCCR 62 radiotherapy RT 62 generation purine nucleoside 62 prostate carcinoma 62 Helicobacter pylori eradication 62 Immunohistochemical staining 62 antiproliferative effects 62 ritonavir boosted 62 elastase 62 fluoropyrimidine 62 mycophenolic acid 62 saline placebo 62 IFN β 62 debulking surgery 62 GW# [003] 62 anticholinergic agents 62 unresectable tumors 62 immunomodulatory therapy 62 heparanase 62 caspofungin 62 platelet inhibitor 62 beta interferons 62 Pegylated Interferon 62 LHRH receptor positive 62 bronchoalveolar lavage 62 pamidronate 62 cetuximab Erbitux R 62 TKI therapy 62 gonadotrophin releasing hormone 62 anti angiogenic agents 62 endothelial activation 62 erythropoietic 62 tumor histology 62 mitomycin 62 monoclonal anti 62 lymphomas leukemias 61 potently inhibited 61 nucleoside analog 61 mediated inhibition 61 syngeneic 61 colorectal carcinoma 61 antiarrhythmic 61 TLK# 61 p# MAP kinase inhibitor 61 tumorigenicity 61 uridine triacetate 61 metaplasia 61 peptide conjugated 61 pegylated liposomal doxorubicin 61 pentoxifylline 61 Onconase 61 annexin 61 HDACi 61 ERalpha 61 thymectomy 61 Prognostic significance 61 murine models 61 Myelodysplastic Syndrome MDS 61 Cyclosporin 61 colon carcinoma 61 cardiac repolarization 61 lenalidomide dexamethasone 61 chemoresistant 61 myeloid metaplasia 61 ductal adenocarcinoma 61 lenalidomide Revlimid R 61 adalimumab Humira 61 Initiate Clinical Trial 61 Azacitidine 61 SSc 61 noninferior 61 bovine thrombin 61 radiosensitivity 61 Alequel 61 MyVax ® 61 Angiotensin Converting Enzyme 61 serum TSH 61 administered subcutaneously 61 Xelox 61 Upregulation 61 potent cytotoxic 61 gemcitabine cisplatin 61 Leydig cell 61 renoprotective 61 nonmetastatic 61 Capesaris 61 p# inhibitor 61 Antiangiogenic 61 HLA DR4 61 estramustine 61 pharmacokinetic interactions 61 muscarinic 61 isoenzyme 61 oral prodrug 61 lesional 61 OvaRex MAb 61 viral kinetics 61 targeted radiotherapeutic 61 patientswith 61 genotypic resistance 61 Pemetrexed 61 picomolar 61 tumor xenograft models 61 lactate dehydrogenase 61 chloride secretion 61 biliary tract cancer 61 Estrogen Receptor 61 angiogenic therapy 61 sunitinib Sutent 61 Factor VIIa 61 TNFalpha 60 vascular disrupting agents 60 pentostatin 60 ceftazidime 60 2DG 60 irreversible inhibitor 60 selective agonist 60 trastuzumab Herceptin ® 60 antibody MAb 60 fosbretabulin 60 antiangiogenic agent 60 receptor blockers 60 idarubicin 60 multikinase inhibitor 60 pouchitis 60 novel immunotherapeutic 60 intratympanic 60 thyroid carcinoma 60 NSAID induced 60 comparator arm 60 Aflibercept 60 ovarian carcinoma 60 vidofludimus 60 gastrointestinal stromal tumors GISTs 60 myelodysplastic myeloproliferative diseases 60 intraperitoneally 60 Carvedilol 60 Lenalidomide 60 piroxicam 60 epoetin alpha 60 NTx 60 cyclin dependent kinase inhibitor 60 Alanine 60 Gleevec resistant 60 pan HDAC inhibitor 60 receptor monoclonal antibody 60 pharmacodynamic endpoints 60 parasitemia 60 micafungin 60 receptor blocker 60 polycythemia vera essential thrombocythemia 60 abacavir Ziagen 60 bevacizumab Avastin R 60 thyroglobulin 60 radioimmunotherapy RIT 60 gastric adenocarcinoma 60 μmol L 60 lactate dehydrogenase LDH 60 isoproterenol 60 plasmid encoding 60 experimentally induced 60 RAV# 60 IGFBP 3 60 mitoxantrone chemotherapy 60 xenograft 60 sitaxsentan 60 PEGylated interferon 60 clinicopathological 60 allograft rejection 60 mesilate 60 BCG refractory 60 RRM1 60 ESBA# 60 inducible nitric oxide synthase 60 pg mL 60 mTOR inhibitors 60 non nucleoside 60 verteporfin 60 eribulin mesylate 60 pyridostigmine 60 CINTREDEKIN BESUDOTOX 60 bisoprolol 60 protein tyrosine phosphatase 1B 60 1beta 60 Aurora Kinase 60 leukocyte count 60 A3 adenosine receptor 60 irinotecan oxaliplatin 60 daily subcutaneous injections 60 esophageal gastric 60 gene polymorphism 60 salmeterol fluticasone 60 urothelial cancer 60 intravesical therapy 60 edifoligide E2F Decoy 60 pharmacokinetic PK study 60 hepatoma 60 temozolomide TMZ 60 pancreatic adenocarcinoma 60 erlotinib Tarceva 60 immunoconjugate 60 CEACAM1 60 surgically resected 60 EGFR HER2 60 orally inhaled 59 Modrenal 59 AT1 receptor 59 pT3 59 depsipeptide 59 pharmacodynamic PD 59 immunosuppressive regimen 59 pT2 59 diagnostic biomarker 59 AST ALT 59 leukocyte counts 59 chemoradiation therapy 59 cTnI 59 chronic thromboembolic pulmonary 59 Bosentan 59 sedative pentobarbital sodium 59 Doxil ® 59 selectively binds 59 Protein Kinase C 59 PAOD 59 lenalidomide Revlimid 59 palifermin 59 hemorrhagic cystitis 59 metastatic malignant melanoma 59 Zorbtive TM 59 FOLFOX6 59 aurora kinase 59 ritonavir boosted protease inhibitor 59 demethylating agent 59 hypothalamic pituitary 59 anti angiogenic agent 59 PrevOnco 59 NMIBC 59 B7 H3 59 CTAP# Capsules 59 Velcade bortezomib 59 hematological parameters 59 torsade de pointes 59 dasatinib Sprycel ® 59 HCV replicon 59 Gemzar gemcitabine 59 NEUGENE antisense 59 TOP2A 59 beta adrenergic 59 steroidogenesis 59 aripiprazole Abilify 59 omega interferon 59 radiolabeled monoclonal antibody 59 intratumoral 59 hematopoietic cancers 59 HSP# inhibitor 59 concurrent chemoradiation 59 antiarrhythmic drug 59 dasatinib Sprycel 59 Pegylated Liposomal Doxorubicin 59 Pgp 59 trans retinoic acid 59 flecainide 59 IAP inhibitor 59 histological subtype 59 PEGylated 59 Novartis Reclast 59 allogeneic hematopoietic stem cell 59 undergoing liver transplantation 59 bioavailable testosterone 59 4mg/kg 59 gastric carcinoma 59 cisplatin resistant 59 LPS induced 59 adriamycin 59 morpholino 59 ibritumomab tiuxetan 59 liver metastasis 59 gemcitabine carboplatin 59 antimitotic 59 secondary hyperparathyroidism 59 receptor tyrosine kinase inhibitor 59 corticosteroid dexamethasone 59 peripheral blood mononuclear 59 antidiabetic drugs 59 induced phosphorylation 59 diabetes mellitus DM 59 hyperacute 59 covalently bound 59 surgically resectable 59 leflunomide 59 cerebral vasospasm 59 cranial irradiation 59 metastatic lymph nodes 59 HER2 amplification 59 transgene expression 59 basiliximab 59 Adjunctive 59 NSCLC tumors 59 galiximab 59 nanomolar 59 Immunohistochemical analysis 59 Cytoxan ® 59 gastric carcinomas 59 ® lenalidomide 59 urothelial carcinoma 59 therapeutically relevant 59 intravesical instillation 59 C#BL 6 mice 59 Azathioprine 59 vitro cytotoxicity 59 SERCA2a 59 null responder 59 intravenous immunoglobulin IVIg 59 Omacetaxine 59 anthracycline containing 59 miglustat 59 vapreotide acetate 59 ara C 59 hypercholesterolemic 59 Immunotherapeutic 59 carcinoembryonic antigen 59 mapatumumab 59 hPAM4 59 NOD SCID mice 59 essential thrombocythemia ET 59 metastatic gastric 59 relapsed MM 59 Interferon Alfa 59 PROSTVAC VF 59 induced neuropathy 59 leukemia AML 59 PTK# 59 glatiramer acetate GA 59 ablative therapy 59 NF kappaB activation 59 LAB CGRP 59 gp# protein [002] 59 somatostatin receptor 59 paclitaxel poliglumex 59 Nebulized 59 tipranavir ritonavir 59 G CSFs 59 microsatellite instability 59 Panzem R NCD 59 treat benign prostatic 59 kinase inhibition 59 PKC inhibitor 58 alfuzosin 58 erlotinib Tarceva ® 58 colorectal liver metastases 58 Fenretinide 58 Noxafil 58 DNA intercalator 58 danazol 58 Platinol ® 58 58 paricalcitol 58 somatostatin analogue 58 Fluconazole 58 urography 58 elevated transaminases 58 ACTOS ® 58 clomipramine 58 hepatocellular carcinomas 58 trastuzumab Herceptin 58 nitrofurantoin 58 LSI #P 58 RhuDex ® 58 metformin XR 58 calcitonin gene related 58 Campath alemtuzumab 58 taxane refractory 58 PARP inhibition 58 Anavex #-# 58 microsomal 58 VNP#M 58 epithelial tumors 58 pg ml 58 favorable pharmacokinetic profile 58 subcutaneously injected 58 adipogenic 58 lapatinib Tykerb 58 miRNA biomarkers 58 Dacogen decitabine 58 Clusterin 58 pro angiogenic 58 xenograft model 58 Ropinirole 58 bullous 58 cinacalcet 58 labetalol 58 Ferinject R 58 M1 muscarinic 58 chemoradiotherapy 58 Myoglobin 58 ongoing Phase 1b 58 CLL SLL 58 orally bioavailable 58 PPAR gamma agonist 58 TLR8 agonist 58 antiangiogenic therapy 58 adenosine A2A 58 cynomolgus monkeys 58 PSN# [002] 58 neurologic progression 58 HIF 1a 58 SGPT 58 allergic airway inflammation 58 gemcitabine Gemzar 58 hypomethylating agent 58 intracerebral 58 preclinical efficacy 58 interferon ribavirin 58 subcutaneously administered 58 huN# DM1 58 atherosclerotic renal artery stenosis 58 chemo immunotherapy 58 selective cerebral perfusion 58 T#I [002] 58 UGT#A# 58 pmol L 58 insulin glulisine 58 alemtuzumab MS 58 QT QTc 58 urodynamic 58 Immunomodulatory 58 EndoTAG 58 multicenter Phase II 58 scintigraphic 58 muscarinic receptors 58 5alpha reductase 58 IL 1ß 58 5 fluorouracil leucovorin 58 bFGF 58 mononuclear 58 MTHFR 58 Elitek 58 gastrointestinal perforation 58 GP IIb IIIa inhibitors 58 Pharmacokinetics PK 58 Irinotecan 58 TLR9 agonist 58 anti fibrotic 58 VAPRISOL 58 inhibitor rofecoxib 58 Intra arterial 58 Triapine 58 Bleomycin 58 independent prognostic marker 58 potency selectivity 58 xenograft models 58 MMP2 58 epigenetic therapies 58 pulmonary arterial 58 Mycophenolate Mofetil 58 HLA A2 58 IV Busulfex 58 Virologic 58 dexamethasone Decadron 58 carcinoids 58 Mitomycin C 58 tumors GIST 58 mitochondrial toxicity 58 colorectal adenoma 58 rHuEPO 58 Natalizumab 58 BrachySil ™ 58 hydroxylase 58 HER2/neu 58 ONCASPAR 58 radiotherapeutic 58 vWF 58 PI3 kinase inhibitor 58 RhuDex 58 muscarinic antagonist 58 personalized immunotherapy 58 dimeglumine 58 plasma uric acid 58 DAVANAT 58 ribavirin USP 58 QRS interval 58 hematological relapse 58 #HT#A 58 intrahepatic 58 Annexin V 58 targeted antifolate 58 castrate resistant 58 normoxic 58 renal toxicity 58 paclitaxel Taxol 58 paclitaxel carboplatin 58 ibandronate 58 PIGF 58 metalloproteinase 58 ACTOplus met XR 58 Patients Treated With 58 relapsed ALL 58 polyclonal 58 vivo potency 58 intravesical 58 B Cell Lymphoma 58 NV1FGF 58 histone deacetylase HDAC inhibitor 58 Kamada AAT 58 azacytidine 58 cediranib 58 antihyperglycemic 58 bevacizumab Avastin ® 58 cilengitide 58 Copegus ribavirin 58 GHRH 58 5FU 58 intradermal injections 58 AGGRASTAT R Injection tirofiban 58 oblimersen 58 intra arterial 58 leuprorelin 58 PKCi 58 HLA DRB1 * 58 nitroprusside 58 olmesartan 58 nimodipine 58 docetaxel Taxotere 58 pulmonary resection 58 IFN α 58 endometrial hyperplasia 58 superficial femoral 58 Degarelix 57 polycythemia vera PV 57 atrial natriuretic peptide 57 temozolomide Temodar 57 GSTP1 57 mutated KRAS 57 selegiline 57 PPARgamma 57 Osteopontin 57 Vernakalant 57 GMX# 57 Trofex 57 irbesartan 57 etoposide 57 metastatic colorectal 57 endothelium dependent 57 mycophenolate mofetil 57 transabdominal 57 Barrett esophagus BE 57 flavopiridol 57 subcutaneous SC 57 adjuvant cisplatin 57 Adefovir 57 metastatic neuroendocrine tumors 57 bladder carcinoma 57 Androxal TM 57 Interferon alfa 57 radiolabeled 57 Fibrillex 57 peg interferon 57 immunosuppressant drug 57 Î ² 57 ALGRX 57 systemic RNAi therapeutic 57 SELZENTRY 57 Temozolomide 57 Achieves Primary Endpoint 57 prostate cancer CaP 57 anti CD3 antibody 57 prostate adenocarcinoma 57 prolonged QT interval 57 Janus Kinase 57 topoisomerase II inhibitor 57 relapsed ovarian cancer 57 imatinib resistant 57 teratogenicity 57 Lp PLA 2 57 intravenous cyclophosphamide 57 adult mesenchymal stem 57 Bevacizumab Avastin 57 adenomatous 57 chemokine receptor 57 refractory colorectal cancer 57 serum urate levels 57 PLA2 57 prostate cancer PCa 57 HepG2 cells 57 histologically proven 57 Serum concentrations 57 mecasermin 57 peptide BNP 57 autologous SCT 57 endocrinologic 57 serum PTH 57 JAK2 V#F 57 Panzem R 57 PEGPH# 57 captopril 57 dose proportionality 57 #β estradiol 57 CIMZIA TM 57 Liposomal 57 rt PA 57 PSN# [001] 57 Moxifloxacin 57 alpha 2a 57 combretastatin A4 phosphate CA4P 57 pharmacodynamic profile 57 HER2 antibody 57 microdose 57 alfa 2a 57 mCi 57 nmol liter 57 hepatorenal syndrome 57 hENT1 57 5 Fluorouracil 57 Intravitreal 57 Cytochrome P# 57 Xanafide 57 Prothrombin 57 Navelbine R 57 EGFR TKI 57 pancreatic islet cell 57 doxorubicin docetaxel 57 hepatotoxicity 57 apolipoproteins 57 IFN γ 57 recurrent acute pancreatitis 57 Retreatment 57 Surgical resection 57 Antiviral Therapy 57 Multiple Myeloma MM 57 tumor specific antigen 57 subcutaneous immunoglobulin 57 intracavitary 57 ATL# [001] 57 Gonal f R 57 Angiotensin II 57 glomerular 57 farletuzumab 57 leukotriene B4 57 interleukin IL -6 57 FOLFIRI alone 57 AGHD 57 pancreatic neuroendocrine tumors 57 gastric retentive 57 refractory acute myeloid 57 imatinib Gleevec ® 57 quetiapine Seroquel 57 bendamustine 57 triiodothyronine 57 reteplase 57 fallopian tube carcinoma 57 Annamycin 57 pancreatic carcinoma 57 HeFH 57 pulmonary toxicity 57 effector function 57 acute myeloid 57 fluvastatin 57 DAPT 57 cellular cytotoxicity 57 everolimus eluting stents 57 Creatinine 57 colorectal cancer liver metastases 57 neoplastic cells 57 cell adhesion molecule 57 glucocorticoid induced 57 localized renal 57 transarterial 57 CC genotype 57 carmustine 57 induces apoptosis 57 efavirenz EFV 57 gemtuzumab ozogamicin 57 pertuzumab 57 μg ml 57 tumor subtypes 57 hypoxia inducible factor 57 dalteparin 57 mucinous 57 vernakalant hydrochloride 57 AMEVIVE 57 grade cervical intraepithelial 57 molecular remissions 57 prostanoid 57 atypical hemolytic uremic syndrome 57 leukemia CLL 57 metastatic renal cell carcinoma 57 refractory ovarian cancer 57 alpha fetoprotein AFP 57 peripheral arterial 57 anagrelide 57 Inhalation Solution 57 coronary vascular 57 immunostaining 57 oral clodronate 57 hapten 57 fludarabine cyclophosphamide 57 antifibrinolytic 57 Flu Cy 57 Torsades de Pointes 57 Selective inhibition 57 ALK inhibitors 57 potassium sparing diuretics 57 florbetaben 57 myeloablative 57 Cloretazine 57 Quinamed 57 transplantation HCT 57 Ceflatonin 57 intratumoral injection 57 acetonide FA 57 Fas ligand 57 Cimzia TM 57 hESC derived cardiomyocytes 57 vasopressor 57 candesartan cilexetil 57 tiuxetan 57 idiopathic myelofibrosis 57 IgG4 57 pancreatic transplantation 57 PDE4 inhibitor 57 diarrhea predominant irritable 57 pancreatic ductal 57 ^ sup #m 57 CYP#D# inhibitor 57 unfractionated heparin UFH 57 palliative radiotherapy 57 Pim kinases 57 endothelin receptor 57 TNF therapy 57 nucleoside nucleotide 57 baseline LDH 56 doxorubicin HCl 56 immunotherapeutic vaccine 56 haematological cancers 56 Allogeneic 56 bortezomib Velcade R 56 proteasome inhibitor 56 Thrombin 56 substantially excreted 56 IMC #B 56 biochemical relapse 56 metastatic uveal melanoma 56 EGFR tyrosine kinase inhibitors 56 Advagraf 56 Vaprisol 56 S/GSK# 56 neurocognitive outcomes 56 aspartate aminotransferase 56 natriuretic peptide 56 esophagogastric 56 Tacrolimus 56 oxysterols 56 IL# PE#QQR 56 KSP inhibitors 56 CGRP 56 ZACTIMA 56 PSMA ADC 56 ORENCIA ® 56 stratifying patients 56 bortezomib Velcade ® 56 cancer mCRC 56 ERK1 2 56 intravitreal implant 56 PAM4 56 imatinib therapy 56 hepatic liver 56 canakinumab 56 exocrine pancreas 56 cytotoxicity assays 56 HBV vaccine 56 hepatic encephalopathy HE 56 multiple myeloma MM 56 IgG1 antibody 56 NRTI resistance 56 pramlintide metreleptin combination 56 Idiopathic Pulmonary Fibrosis 56 inotropic 56 flow cytometric 56 concomitant medications 56 CCR9 56 etiologic 56 fulvestrant 56 CsA 56 intraepithelial neoplasia 56 thromboembolic complications 56 pomalidomide 56 aPTT 56 retinal vein occlusion induced 56 INVEGA ® 56 rFSH 56 immunohistochemical 56 haematologic malignancies 56 Resten NG 56 #:#-# [031] 56 percutaneous drainage 56 Hcy 56 Chronic Myeloid Leukemia CML 56 antiemetics 56 5 hydroxytryptamine 56 Phase #b/#a trial 56 decellularized 56 malignant ovarian 56 eosinophilic asthma 56 artery stenosis 56 adenoviral 56 ART# 56 adenylate cyclase 56 immunomodulatory therapies 56 pleural fluid 56 lutropin alfa 56 Apoptone 56 glutamyl 56 idiotype vaccine 56 luteal 56 valvular heart disease 56 Lantus insulin 56 pegfilgrastim 56 occlusive disease 56 p# mitogen activated 56 HIV RNA 56 T2DM 56 virus AAV 56 ERBB2 56 vivo validation 56 enfuvirtide 56 antiresorptive 56 allogeneic HSCT 56 vitro pharmacology 56 haematological 56 hepatocellular carcinoma liver 56 mRNA expression 56 Virulizin ® 56 metabolizing enzyme 56 TPV r 56 cells PBMC 56 aortic root replacement 56 resectable 56 iodixanol 56 FVIIa 56 EGS# 56 rosiglitazone maleate 56 neoadjuvant setting 56 Melphalan 56 cetuximab Erbitux 56 antithrombotic agent 56 deletion 5q 56 TNFα 56 Atherosclerotic 56 HCV Genotype 56 hypertension PAH 56 aromatase inhibitor therapy 56 recombinant adeno associated 56 plasma adiponectin 56 alkaline phosphatase ALP 56 uM 56 pharmacodynamics PD 56 injected intramuscularly 56 gastrointestinal stromal tumors GIST 56 thrombocytosis 56 TNF α 56 deferiprone 56 sipuleucel T 56 NovoTTF #A 56 mTOR inhibitor 56 intracoronary 56 FLT3 56 DEB# 56 mineralocorticoid receptor 56 uPA 56 Legg Calvé Perthes disease 56 DURIN TM 56 nonischemic 56 Losartan 56 E selectin 56 humanized monoclonal antibodies 56 HIV HCV coinfected 56 antisense inhibitor 56 acetylcysteine 56 Solid Tumors criteria 56 thrombocytopenic 56 Roche Herceptin 56 antiarrhythmics 56 pediatric pontine glioma 56 Sprycel dasatinib 56 colony stimulating factor 56 interferon alfa 2a 56 Erlotinib 56 atazanavir ritonavir 56 anti Xa 56 PROCRIT R 56 polyamine 56 imatinib Gleevec 56 diabetic kidney 56 Leucovorin 56 HSCT 56 MYCN amplification 56 MENOPUR ® 56 mediastinitis 56 Neulasta R 56 exocrine pancreatic insufficiency EPI 56 MAb 56 pathologic diagnosis 56 Monoclonal antibody 56 HNSCC 56 TIMP 56 calcitriol 56 gonadotrophin releasing hormone GnRH 56 CHOP chemotherapy 56 pegylated interferon alfa 56 T1a 56 ATTR CM 56 neutropenic 56 ErbB2 positive 56 cidofovir 56 Zarnestra 56 atazanavir Reyataz 56 Teriparatide 56 TRAIL R2 56 sunitinib malate